Abstract
Silver staining nucleolar organiser regions (AgNOR’s) were determined in archival histological specimens of breast carcinoma. Representative samples from forty-eight female patients were counted manually for AgNOR’s — median 3.85 (range 1.1–10.2 AgNOR’s per cell). Taking the median value of 3.85 as a cutoff, the patients were divided into two groups:
A = Those with AgNOR counts > 3.85
B = Patients with AgNOR counts ≤ 3.85
The 5 year survival was 21% in group A and 85% in group B (p<0.001). There was no significant correlation between AgNOR’s and tumour size, lymph node status, tumour grade, menopausal status and oestrogen receptors. We conclude that nucleolar organiser regions may be useful as a prognostic indicator in breast carcinoma especially in patients in whom other prognostic information is unavailable.
Similar content being viewed by others
References
Fisher, B., Bauer, M., Wicherhan, L., Redmond, C. K., Fisher, E. R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983: 52, 151–1157.
Butler, J. A., Bretsky, S., Menendez-Botety, C., Kinne, D. W. Oestrogen receptor protein of breast cancer as a predictor of recurrence cancer. 1986: 58, 2662–2670.
Davis, B. W., Gelber, R. D., Goldhirsh, Aet al. Prognostic significance of tumour grade in clinical trials of adjuvant therapy for breast cancer with axillary lymh node metastases. Cancer 1986: 58, 2662- 2670.
Russo, J., Frederick, J., Ownby, H. E. et al. Predictors of recurrencee and survival of patients with breast cancer. Am. J. Clin. Path. 1987: 123–131.
Locker, A. P., Ellis, I. O., Morgan, D. A. L., Elston, C. W., Mitchell, A., Blarney, R. W. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br. J. Surg. 1989: 76, 890–894.
Fakan, S., Hemandez-Verdun, D. The nucleolus and the nucleolar organiser regions. Biol. Cell. 1986: 56, 189–206.
Stachl, A. The nucleus and neucleolar chromosomes. Jordan E. G.,Cullis,C. A. (Eds.). The Nucleolus. Cambridge University Press 1982: 1–24.
Goodpasture, C., Bloom, S. E. Visualisation of nucleolar organiser regions in mammalian chromosomes using silver staining. Chromosoma 1975: 53, 37–50.
Reeves, B. R., Casey, G., Harris, H. Variations in the activity of nucleolar organisers in different tissues, demonstrated by silver staining of human normal and leukemic cells. Cancer Genet. Cytogenet. 1982: 6, 223–230.
Hehir, D. J., Seifalian, A., Parbhoo, S. P. An automated system for the evaluation of AgNOR’s in female breast carcinoma. Brit. J. Cancer, 1990; 62: 538 (a).
Schwarzacher, H. G., Wachtier, F. Nucleolar organiser regions and nucleoli. Hum. Genet. 1983: 64, 89–99.
Ploton, D., Menager, M., Jeanesson, P., Himber, G., Pigeon, F., Adnet, J. Improvement in the staining and in the visualisation of argryphilic proteins of the nucleolar organiser region at the optical level. Hisochem. J. 1986: 18, 5–14.
Giri, D. D., Nottingham, J. F., Lawrey, J. Dundas, S. A. C., Underwood, J. C. E. Silver-binding nucleolar organiser regions (Ag-NORs) in benign and malignant breast lesions: Correlations with ploidy and growth phase by DNA flow cystometry. J. Path. 1989: 157, 307–313.
Moran, K., Cooke, T. Forster, G.et al. Prognostic value of nucleolar organiser regions and ploidy values in advanced colorectal cancer. Br. J. Surg. 1989: 76, 1152–1155.
Dervan, P. A., Gilmartin, L. G., Loftus, B. M., Carney, D. M. Argyrophilic nucleolar organiser counts correlate with the Ki scores. Am. J. Clin. Path. 1989: 4501–407.
Smith, R. J., Crocker, J. Evaluation of nucleolar organizer regionassociated proteins in breast malignancy. Histopathology 1988: 122, 113–125.
Raymond, W. A., Leong, A. S. Nucleolar organiser regions relate to growth fractions in human breast carcinoma. Hum. Pathol. 1989: 8, 741–746.
Cronin, K., Loftus, B., Dervan, P. A. Are AgNORs useful in differentiating follicular lymphoma from follicular hyperplasia ?. J. Clin. Path. 1989: 12.
Bloom, H. J. C., Richardson, W. W. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br. J. Cancer 1957: 11, 359–377.
Kaplan. E. L., Meier, T. Non-parametric estimation of incomplete observations. J. Am. Stat. Assoc. 1958: 53, 457–481.
Peto, R., Pike, M. C., Armitage, P.et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br. J. Cancer 1977: 35, 1–29.
Crocker, J., Skilbeck, N. Nucleolar organizer region associated proteins in cutaneous melanotic lesions: a quantitative study. J. Clin. Path. 1987: 40, 885–889.
Egan, M. J., Raafat, F., Crocker, J. et al. Nucleolar organizer regions in fibrous proliferations of childhood and infantile fibrosarcoma. J. Clin Path 1988: 41, 31–33.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hehir, D.J., Cronin, K.J., Dervan, P.A. et al. Argyrophylic nucleolar organiser regions (AgNOR’s) as a prognostic indicator in breast carcinoma. I.J.M.S. 161, 112–115 (1992). https://doi.org/10.1007/BF02983761
Issue Date:
DOI: https://doi.org/10.1007/BF02983761